دورية أكاديمية

Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.

التفاصيل البيبلوغرافية
العنوان: Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
المؤلفون: Traub AM, Medley A, Gross J, Sloan M, Amzel A, Gleason MM, Fernando NB, Wong V, Grillo MP, Wolf HT, Al-Samarrai T, Frawley A, Segwabe M, Motswere C, Baramperanye E, Nzima V, Mange Mayer M, Balachandra S, N'siesi FX, Longuma HO, Nyembo P, Mazibuko S, Tilahun T, Teferi W, Desinor O, Reginald JL, Simiyu T, Nyabiage L, Mirembe J, Ts'oeu M, Zomba G, Nyangulu M, Wate A, Greenberg Cowan J, Mali D, Pietersen I, Ogundehin D, Onotu D, Ikpeazu A, Niyonsaba E, Bamwesigye J, Mabasa H, Kindra G, Bunga S, Rwegerera F, Machage E, King'ori G, Calnan J, Nazziwa E, Lingenda G, Musokotwane K, Bulaya-Tembo R, Maphosa T, Srivastava M
المصدر: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Jul 15; Vol. 71 (28), pp. 894-898. Date of Electronic Publication: 2022 Jul 15.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
أسماء مطبوعة: Publication: Atlanta, GA : U.S. Centers for Disease Control
Original Publication: [Atlanta] U. S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control.
مواضيع طبية MeSH: Acquired Immunodeficiency Syndrome*/epidemiology , COVID-19*/epidemiology , HIV Infections*/diagnosis , HIV Infections*/epidemiology, Adolescent ; Child ; HIV Testing ; Humans ; Pandemics
مستخلص: During 2020, an estimated 150,000 persons aged 0-14 years acquired HIV globally (1). Case identification is the first step to ensure children living with HIV are linked to life-saving treatment, achieve viral suppression, and live long, healthy lives. Successful interventions to optimize pediatric HIV testing during the COVID-19 pandemic are needed to sustain progress toward achieving Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets.* Changes in HIV testing and diagnoses among persons aged 1-14 years (children) were assessed in 22 U.S. President's Emergency Plan for AIDS Relief (PEPFAR)-supported countries during October 1, 2019-September 30, 2020. This period corresponds to the two fiscal quarters before the COVID-19 pandemic (i.e., Q1 and Q2) and the two quarters after the pandemic began (i.e., Q3 and Q4). Testing was disaggregated by age group, testing strategy, and fiscal year quarter. During October 2019-September 2020, PEPFAR supported 4,312,343 HIV tests and identified 74,658 children living with HIV (CLHIV). The number of HIV tests performed was similar during Q1 and Q2, decreased 40.1% from Q2 to Q3, and increased 19.7% from Q3 to Q4. The number of HIV cases identified among children aged 1-14 years (cases identified) increased 7.4% from Q1 to Q2, decreased 29.4% from Q2 to Q3, and increased 3.3% from Q3 to Q4. Although testing in outpatient departments decreased 21% from Q1 to Q4, testing from other strategies increased during the same period, including mobile testing by 38%, facility-based index testing (offering an HIV test to partners and biological children of persons living with HIV) by 8%, and testing children with signs or symptoms of malnutrition within health facilities by 7%. In addition, most tests (61.3%) and cases identified (60.9%) were among children aged 5-14 years (school-aged children), highlighting the need to continue offering HIV testing to older children. These findings provide important information on the most effective strategies for identifying CLHIV during the COVID-19 pandemic. HIV testing programs should continue to use programmatic, surveillance, and financial data at both national and subnational levels to determine the optimal mix of testing strategies to minimize disruptions in pediatric case identification during the COVID-19 pandemic.
Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
References: PLoS Med. 2017 Jul 25;14(7):e1002360. (PMID: 28742829)
AIDS. 2019 Feb 1;33(2):349-352. (PMID: 30557162)
PLoS One. 2020 Sep 18;15(9):e0239163. (PMID: 32946528)
Implement Sci Commun. 2021 Jul 5;2(1):73. (PMID: 34225820)
Int J Epidemiol. 2011 Apr;40(2):385-96. (PMID: 21247884)
تواريخ الأحداث: Date Created: 20220714 Date Completed: 20220718 Latest Revision: 20220731
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9290390
DOI: 10.15585/mmwr.mm7128a2
PMID: 35834422
قاعدة البيانات: MEDLINE
الوصف
تدمد:1545-861X
DOI:10.15585/mmwr.mm7128a2